TOLLIP and idiopathic pulmonary fibrosis: The TOLLIP rs3750920 polymorphism instead seems to influence the response of IPF to treatment, particularly a study by Oldham et al. in the pre-antifibrotic era that showed better results with N-Acetylcysteine treatment in carriers of this SNP [64].